Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-24
DOI
10.3389/fcvm.2022.966331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Open-access database of literature derived drug-related Torsade de Pointes cases
- (2022) Laura Krumpholz et al. BMC Pharmacology & Toxicology
- Recommendations on off‐label use of intravenous azithromycin in children
- (2021) Pengxiang Zhou et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections
- (2021) Ruwen Böhm et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status
- (2021) Robert L. Findling et al. CNS DRUGS
- Drug-induced QT Prolongation Atlas (DIQTA) for enhancing cardiotoxicity management
- (2021) Shihai Li et al. DRUG DISCOVERY TODAY
- Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
- (2020) Ola Caster et al. DRUG SAFETY
- Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
- (2020) James E. Tisdale et al. CIRCULATION
- Effect of age and gender on the QTc-interval in healthy individuals and patients with long-QT syndrome
- (2018) Arja Suzanne Vink et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Sex-related Differences in Drug-induced QT Prolongation and Torsades de Pointes: a New Model System with Human iPSC-CMs
- (2018) Jianhua Huo et al. TOXICOLOGICAL SCIENCES
- Prevalence of Torsades de Pointes inducing drugs usage among elderly outpatients in North Jordan Hospitals
- (2018) Ahmad Al-Azayzih et al. SAUDI PHARMACEUTICAL JOURNAL
- Incidence of Torsade de Pointes in a tertiary hospital population
- (2017) Eline Vandael et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Use of data mining at the Food and Drug Administration
- (2015) Hesha J Duggirala et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe
- (2015) Elisabetta Poluzzi et al. PLoS One
- QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
- (2013) Katy E. Trinkley et al. CURRENT MEDICAL RESEARCH AND OPINION
- Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
- (2013) Elisabetta Poluzzi et al. DRUG SAFETY
- Data Mining of the Public Version of the FDA Adverse Event Reporting System
- (2013) Toshiyuki Sakaeda et al. International Journal of Medical Sciences
- Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?
- (2012) Rashmi R. Shah BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- OpenVigil—free eyeballs on AERS pharmacovigilance data
- (2012) Ruwen Böhm et al. NATURE BIOTECHNOLOGY
- Selected control events and reporting odds ratio in signal detection methodology
- (2010) Nobuhiro Ooba et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance
- (2009) B Darpo BRITISH JOURNAL OF PHARMACOLOGY
- Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)
- (2009) Elisabetta Poluzzi et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started